M 315 (Ondansetron 4 mg)
Pill imprint M 315 has been identified as Ondansetron hydrochloride 4 mg.
Ondansetron is used in the treatment of nausea/vomiting, chemotherapy induced; nausea/vomiting; alcohol dependence; gastroenteritis; nausea/vomiting, postoperative (and more), and belongs to the drug class 5HT3 receptor antagonists. There is no proven risk in humans during pregnancy. Ondansetron 4 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for M 315 (Ondansetron 4 mg)
- 4 mg
- 6.00 mm
- Prescription only
- Drug Class:
- 5HT3 receptor antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|51079-0524||UDL Laboratories Inc|
Note: Inactive ingredients may vary.
Ondansetron hydrochloride is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...